Citation Impact
Citing Papers
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Infective Endocarditis
2005 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia
1996
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
2003
Comparison of Overall Obesity and Body Fat Distribution in Predicting Risk of Mortality
2009
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Rapid one-step whole blood C–reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation
2005
Effect of Antimicrobial Use and Other Risk Factors on Antimicrobial Resistance in Pneumococci
1997
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
High Alcohol Intake as a Risk and Prognostic Factor for Community-Acquired Pneumonia
1995
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
1996
Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia
1995
Treatment of Community-Acquired Pneumonia in Outpatients: Randomized Study of Clarithromycin Alone versus Clarithromycin and Cefuroxime
1999
Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia
1996
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Deaths in Bacteremic Pneumococcal Pneumonia
1993
Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia
1993
Early responses to infection: chemokines as mediators of inflammation
1997
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
1997
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
2005
Community-acquired pneumonia
2003
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
2011
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]
2006
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
1998
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZ
2009
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Effect of body mass index on the outcome of infections: a systematic review
2009
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
2005
Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa
2002
Processes and Outcomes of Care for Patients With Community-Acquired Pneumonia
1999
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
ASSESSING PROGNOSIS AND SELECTING AN INITIAL SITE OF CARE FOR ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA
1998
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study.
1998
Bacterial Coinfection in Influenza
2013
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
2005
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Once‐Daily Sparfloxacin Versus High‐Dosage Amoxicillin in the Treatment of Community‐Acquired, Suspected Pneumococcal Pneumonia in Adults
1998
Usefulness of Procalcitonin as a Marker of Systemic Infection in Emergency Department Patients: A Prospective Study
2002
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
2007
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997
1999
Severity prediction rules in community acquired pneumonia: a validation study
2000
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course
1996
Infections in Patients with Diabetes Mellitus
1999 Standout
The epidemiology of community-acquired pneumonia among hospitalized adults
1997
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
1999 Standout
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008 Standout
Severe Community-Acquired Pneumonia
1994
Actual Causes of Death in the United States, 2000
2004 Standout
Diagnostic and Prognostic Value of Interleukin-6 and C-reactive Protein in Community-acquired Pneumonia
1995
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Microbial biogeography: putting microorganisms on the map
2006 Standout
Development and Validation of a Clinical Prediction Rule for Hospitalization Due to Pneumonia or Influenza or Death during Influenza Epidemics among Community‐Dwelling Elderly Persons
2004
Factors associated with unknown aetiology in patients with community-acquired pneumonia
2002
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors.
1996
Guidelines for the management of adult lower respiratory tract infections
2005
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Frailty in elderly people
2013 Standout
Epidemiology of community-acquired pneumonia in adults: a population-based study
2000
Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia
2009
C-Reactive Protein Is an Independent Predictor of Severity in Community-acquired Pneumonia
2008
Prognosis of community acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response
2007 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Etiology of Community-Acquired Pneumonia:
1999
Pneumonia Acquired in the Community Through Drug-Resistant Streptococcus pneumoniae
1999
Severe Community-acquired Pneumonia
2002
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia
2000
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae
1998
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Insights into the Interaction between Influenza Virus and Pneumococcus
2006
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.
1998
Q Fever
1999 Standout
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Genomic insights that advance the species definition for prokaryotes
2005 Standout
What are Bacterial Species?
2002
The Biology of Chemokines and their Receptors
2000 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin
2006
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
2003
The Impact of Alcohol-Related Diagnoses on Pneumonia Outcomes
1997
Insertion Sequence 1515 in the ply Gene of a Type 1 Clinical Isolate of Streptococcus pneumoniae Abolishes Pneumolysin Expression
2007 StandoutNobel
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Early Response Cytokines and Innate Immunity: Essential Roles for TNF Receptor 1 and Type I IL-1 Receptor During Escherichia coli Pneumonia in Mice
2001
Works of J. Hedlund being referenced
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization
1990
Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia
1997
Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up
2003
Procalcitonin and C-Reactive Protein Levels in Community-Acquired Pneumonia: Correlation with Etiology and Prognosis
2000
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
2004
Incidence, Capsular Types, and Antibiotic Susceptibility of Invasive Streptococcus pneumoniae in Sweden
1995
Dynamics of Penicillin‐Susceptible Clones in Invasive Pneumococcal Disease
2001
Risk of pneumonia in patients previously treated in hospital for pneumonia
1992
Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area
2007
Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia
1994
Activity of trovafloxacin against blood isolates ofStreptococcus pneumoniae in Sweden
1996
Factors of importance for the long term prognosis after hospital treated pneumonia.
1993
Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
1995